GlassScriptPhysician profile
Felix Cohen
NPI 1053717306
$1,710.71
in general payments reported to CMS, 2019-2025
18 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $186 · 2021: $151 · 2022: $329 · 2023: $217 · 2024: $358 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $695.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $694.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $224.11 | 2019-2023 | Liletta |
| Daiichi Sankyo INC. | $184.86 | 2020-2022 | |
| Evofem Biosciences, INC. | $175.16 | 2021-2022 | |
| Hologic Sales and Service, LLC | $159.88 | 2020-2025 | Aptima |
| Coopersurgical, INC. | $153.18 | 2020-2025 | Paragard T 380a, Paragard T 380a |
| Astellas Pharma US INC | $125.69 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $125.00 | 2023 | Myfembree |
| Avion Pharmaceuticals | $115.17 | 2019 | |
| Agile Therapeutics, INC. | $102.42 | 2021-2024 | Twirla |
| Mayne Pharma Commercial LLC | $67.45 | 2024 | |
| Lupin INC. | $59.57 | 2019-2020 | |
| Allergan, INC. | $58.88 | 2019 | |
| Pfizer INC. | $55.68 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $33.53 | 2019-2020 | |
| Qol Medical, LLC | $19.45 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $18.14 | 2019 | |
| Organon LLC | $18.06 | 2023 | Nexplanon |
| Medline Industries LP | $14.48 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.